Allergen immunotherapy on the way to product-based evaluation-a WAO statement. - Wikidata - awgldk - TriplyDB

Allergen immunotherapy on the way to product-based evaluation-a WAO statement.

Allergen immunotherapy on the way to product-based evaluation-a WAO statement.

http://www.wikidata.org/entity/Q43249691

about

Management of the polyallergic patient with allergy immunotherapy: a practice-based approach Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy agein Therapeutic interventions in severe asthma International consensus (ICON) on: clinical consequences of mite hypersensitivity, a global problem.Standardization and Regulation of Allergen Products in the European Union.Molecular diagnosis and precision medicine in allergy management.Comparison of allergenic extracts from different origins: the value of the FDA's bioequivalent allergy unit (BAU).Benefit of SLIT and SCIT for Allergic Rhinitis and Asthma.Natural Evolution of IgE Responses to Mite Allergens and Relationship to Progression of Allergic Disease: a Review.Similar biological activity in skin prick test for Oralair(®) (8200 BAU) and Grazax(®) (6200 BAU) reinforces effective SLIT dosing level.Immunotherapy of house dust mite allergy.Allergen immunotherapy in atopic dermatitis.Lolium perenne peptide immunotherapy is well tolerated and elicits a protective B-cell response in seasonal allergic rhinitis patients.EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis.EAACI guidelines on allergen immunotherapy: Prevention of allergy.A critical appraisal on AIT in childhood asthma.

P2860

Q26772200-3B65A0D0-A05F-4E3B-827A-DF6DF7F25B7B Q28077951-5B14FADE-3D45-4E93-A3F0-5C8A805A17B0 Q28079238-0C83BAEF-E89C-4E02-B85F-9FFC17EDB02A Q33572979-22AEBB25-23FD-4D30-A8DD-C020CA85BD90 Q38732578-CEC4C715-1DA8-4BAD-92C6-22259F321B04 Q38777960-68D6CE3E-428B-4A69-ABCC-A011DEBCB976 Q38842283-1ADF8440-705E-4C1E-ADE2-4A8121A83346 Q39037216-1D398670-E113-4DC5-BF67-5510E2C8339C Q39254046-54960CE5-4D44-4893-88AD-D942DC1348A3 Q40639452-AE046CCD-3E8A-4AA9-8211-57EF036187F4 Q43915564-CBF61266-ADA9-4072-B206-7920B58374D7 Q47644708-51D4147C-3E1F-4F8E-8FB0-29571E61CAB9 Q47660259-69AEC53D-EA0D-4081-96BB-9FFC99B258F0 Q47764778-A8F8C405-521A-4C36-82C7-5A3B44A0EA00 Q47774546-63283DE2-3E47-44E7-9B8C-E5FC3248BAB4 Q55334503-8B57CFFD-35A6-442E-995F-858D7CCE85B4

P2860

Allergen immunotherapy on the way to product-based evaluation-a WAO statement.

http://www.wikidata.org/entity/Q43249691

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Allergen immunotherapy on the way to product-based evaluation-a WAO statement.

@en

Allergen immunotherapy on the way to product-based evaluation-a WAO statement.

@nl

type

label

Allergen immunotherapy on the way to product-based evaluation-a WAO statement.

@en

Allergen immunotherapy on the way to product-based evaluation-a WAO statement.

@nl

prefLabel

Allergen immunotherapy on the way to product-based evaluation-a WAO statement.

@en

Allergen immunotherapy on the way to product-based evaluation-a WAO statement.

@nl

P1433

Q43249691-C13B3380-A733-4999-A6D9-87837993F5F7

P1476

Q43249691-859C57B0-2202-43B8-B0B9-D9307DF76375

P2093

Q43249691-071448CA-ACEC-46DE-B8CA-24AD7B20B7D9

Q43249691-758646C9-4E20-4DF0-BA5C-F9BD936DA767

Q43249691-7F50FF85-F975-43D5-9A87-13C79A22C208

Q43249691-CAEF87A8-FCE7-4CBC-A802-AAEDF287B00E

Q43249691-EF603CEE-00B9-4A1C-AD4F-B25EA9F84AEC

P2860

Q43249691-2914FBDB-B68B-4BA9-AA7C-15A0BF1A5B71

Q43249691-497A146C-FC02-4549-A282-022347C0EEF2

Q43249691-6F197ED9-2AF5-49AC-B4F3-84A215F28D6F

Q43249691-6F5711BD-2F86-4ABA-8426-E44CE334E44D

Q43249691-72046A53-F11C-4316-88A4-FE09C8F0A071

Q43249691-73383FFC-BE0A-4685-9BF3-85217E86616A

Q43249691-7C76B56C-1F13-42F9-A602-BBF513F391AD

Q43249691-AFA62067-073F-4035-AAA7-9684BB7C6088

Q43249691-C78B9954-BCD3-4A53-8B75-C66231F3A681

Q43249691-D8E1B818-CC6E-4EAA-8AAA-ADFC9179818D

P2888

Q43249691-23E2096D-7661-4911-828D-A6DADF1BD435

P304

Q43249691-CC740660-0D4F-4A49-824B-51DF3EF7AFBE

P31

Q43249691-8A1C6257-8F2F-4E57-8954-9E94969E03E8

P356

Q43249691-2F8667DD-1BBC-49A1-B886-4EFEB5976646

P433

Q43249691-13A4FB3A-709C-4593-A6B8-45C49C8D71F9

P478

Q43249691-581AD6C4-37A3-4FF6-8998-F59D3EF2766A

P50

Q43249691-33ABF0DE-465E-4538-BB55-4DE8BFAF983C

Q43249691-3A88606C-036C-41CA-8399-9FD0E1F8340E

Q43249691-B41A2A8F-F670-4C15-9A77-C6CA36C3E46B

Q43249691-BAFB4D00-BC24-4747-B952-91D95CDD6B75

Q43249691-D7ACE1BD-8E68-4198-82A4-B7A8102EF1B5

P577

Q43249691-90CEA268-3368-412A-BA5D-4AD255AE2EC5

P5875

Q43249691-4FEBBB89-FDD6-4276-87E6-4A9AE0E9F7B7

P6179

Q43249691-F5F52778-D115-4A57-B343-29C9EBDA3F6A

P698

Q43249691-65EB8748-6063-446A-973C-8F6D017BE507

P921

Q43249691-168DB2BB-86FF-44EB-894F-B1168DD0179D

P932

Q43249691-EF8E4C70-3A23-40A3-9EB0-C9BD6BDC10E4

P356

S40413-015-0078-8

P1433

The World Allergy Organization Journal

P1476

Allergen immunotherapy on the way to product-based evaluation-a WAO statement.

@en

P2093

Dennis Ledford

http://www.w3.org/2001/XMLSchema#string

Desiree Larenas-Linnemann

http://www.w3.org/2001/XMLSchema#string

Hugo Neffen

http://www.w3.org/2001/XMLSchema#string

Mark Larché

http://www.w3.org/2001/XMLSchema#string

Thomas Kündig

http://www.w3.org/2001/XMLSchema#string

P2860

EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy.

Sublingual immunotherapy: World Allergy Organization position paper 2013 update.

Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.

Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen).

Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce.

Regulatory aspects of allergen-specific immunotherapy: europe sets the scene for a global approach.

The regulatory system in europe with special emphasis on allergen products.

Comparison of allergen immunotherapy practice patterns in the United States and Europe.

Regulatory environment for allergen-specific immunotherapy.

Specific immunotherapy: beyond the clinical scores.

P2888

s40413-015-0078-8

P304

29

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S40413-015-0078-8

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Giorgio Walter Canonica

Giovanni Passalacqua

P577

2015-09-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282356942

http://www.w3.org/2001/XMLSchema#string

P6179

1039627783

http://www.w3.org/2001/XMLSchema#string

P698

26417398

http://www.w3.org/2001/XMLSchema#string

P921

P932

4571059

http://www.w3.org/2001/XMLSchema#string